Although PJS is considered a hereditary condition that carries some of the highest lifetime risks for developing pancreatic cancer, it should be discussed with patients that the benefits and harms of pancreatic cancer surveillance are not well established yet and under investigation. Therefore, it is recommended that surveillance is conducted at centers of expertise in the framework of a study or registry. Level of evidence: moderate/low Strength of recommendation: strong